Patent · US Active

Truncated L1 protein of human papillomavirus type 58

US9738691B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignees

XIAMEN UNIVERSITY · CN
Xiamen Innovax Biotech Co., Ltd. · CN

Inventors

Shaowei Li · Potomac, US
Minxi Wei · Xiamen, CN
Xianglin Kong · Xiamen, CN
Yingbin Wang · Falls Church, US
Jun Zhang · Xiamen, CN
Ningshao Xia · Fujian, CN

Key dates

Filing date	Mar 1, 2016
Grant date	Aug 22, 2017
Priority date	—
Expiry date	Mar 1, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/20034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are an N-terminal truncated L1 protein of the Human Papillomavirus Type 58, a coding sequence and preparation method thereof, and a virus-like particle comprising the protein. Uses of the protein and the virus-like particle in the preparation of a pharmaceutical composition or a vaccine are further provided. The pharmaceutical composition or vaccine is used for prevention of HPV infection and a disease caused by HPV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.